Determine the efficacy and safety of turmeric in the treatment of patients with advanced
cervical cancer. Efficacy will be determined through radiological and histopathological
criteria through the rate of response to treatment, duration of response, the rate of
objective response and disease control, as well as overall survival and disease-free
survival. The safety of therapy will be evaluated according to the Common Terminology
Criteria for Adverse Events (CTCAE) classification